Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
fallback

Veprate 250mg Tablet ER

Prescription Icon
Prescription Required

Marketer

Ryon Pharma

Salt Composition

Divalproex (250mg)

Overview Veprate 250mg Tablet ER

Epileptic seizures and migraine prevention are key uses for the extended-release Veprate 250mg tablet. It's also sometimes prescribed for bipolar disorder management, often alongside other medications. Dosage and frequency are determined individually by your physician to optimize symptom control. Administer with or without food, consistently at the same time daily for maximum efficacy; noticeable effects generally appear within a couple of weeks. Continuous use, as directed, is crucial, even during symptom-free periods, as missed doses can trigger seizures and abrupt cessation may worsen your condition. Gradual discontinuation is essential. Common side effects, usually mild, include headache, visual disturbances, nausea, vomiting, dizziness, fatigue, imbalance, easy bruising, and hypothermia. Report persistent or bothersome side effects to your doctor. Seek immediate medical attention if a skin rash develops. Prolonged use may lead to osteoporosis and increased fracture risk. Rarely, suicidal ideation or behavior may occur; report any mood changes to your physician promptly. Prior to initiating Veprate 250mg ER, disclose any history of cardiac issues, hepatic or renal impairment, urinary difficulties, depression, or suicidal tendencies. Potential drug interactions exist; inform your doctor of all current medications to ensure safety and compatibility. Consult your doctor before altering Veprate usage during pregnancy. Alcohol consumption should be avoided due to the potential for intensified side effects and increased seizure risk. Regular blood tests, pre- and post-treatment, help monitor therapeutic dosage levels.

Uses of Veprate 250mg Tablet ER

Managing epilepsy and seizures | Bipolar disorder therapy | Migraine prophylaxis

Major Benefits of Veprate 250mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Veprate 250mg Extended-Release Tablets can be consumed with or without food, although consistent daily timing is recommended.

Common Side effects of Veprate 250mg Tablet ER:

  • Decreased body temperature
  • Dizziness
  • Sleepiness
  • Tremors
  • Paresthesia (tingling or pricking sensation)
  • Anemia (low number of red blood cells)
  • Decreased sodium level in blood
  • Liver injury
  • Gastrointestinal disturbance
  • Hypersensitivity
  • Deafness
  • Urinary incontinence
  • Increase in body weight
  • Pain during periods

How to use Veprate 250mg Tablet ER:

Administer this medication precisely as your physician directs, adhering to the prescribed dosage and schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Veprate 250mg Extended-Release Tablets can be consumed with or without food, although consistent timing is recommended.

How Veprate 250mg Tablet ER works:

Epileptic seizures are managed by the extended-release Veprate 250mg tablet, an anticonvulsant that reduces heightened, irregular neuronal firing in the brain.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Extended-release Veprate 250mg tablets can induce increased sleepiness when combined with alcohol.

PregnancyPregnancyCONSULT YOUR DOCTOR

Extended-release Veprate 250mg tablets pose a confirmed risk to fetal development and should not be taken during pregnancy. In exceptional, life-threatening circumstances, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.

Breast feedingBreast feedingSAFE IF PRESCRIBED

Extended-release Veprate 250mg tablets are considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no known risk to the infant.

DrivingDrivingUNSAFE

Extended-release Veprate 250mg tablets may induce adverse reactions that could impair driving capabilities.

KidneyKidneySAFE IF PRESCRIBED

Extended-release Veprate 250mg tablets are considered safe for use in individuals with renal impairment. No alteration of the Veprate 250mg extended-release tablet dosage is advised.

LiverLiverUNSAFE

Extended-release Veprate 250mg tablets are likely contraindicated for individuals with hepatic impairment and should be omitted. Seek medical advice.

What if you forget to take Veprate 250mg Tablet ER :

Should you forget a Veprate 250mg Extended-Release tablet, ingest it immediately upon remembrance. If, however, your next scheduled dose is imminent, omit the missed dose and resume your normal medication routine. Never take a double dose.

Facts to Know About Veprate 250mg Tablet ER

LabelValue
Chemical Type Derivatives of Aliphatic Carboxylic Acids
Developing Habits No.
Treatment Category Neuroscience (Central Nervous System)
Actions Antiepileptic drugs targeting sodium channels

FAQs on Veprate 250mg Tablet ER

Always consult your doctor before discontinuing Veprate 250mg Tablet ER. Withdrawal should be gradual and supervised to minimize the risk of symptom recurrence, including irritability, anxiety, dizziness, and tremors. Abrupt cessation may be harmful.
Veprate 250mg Extended-Release tablets may be used to stabilize mood in individuals experiencing rapid mood swings. The medication achieves this by reducing excessive brain activity associated with these fluctuations.
Veprate 250mg ER tablets can cause weight gain, possibly due to increased appetite. Maintain a healthy diet and exercise to mitigate this. Consult your doctor about any weight concerns.
Veprate 250mg Extended-Release Tablets can cause drowsiness. Refrain from driving or activities demanding concentration until you understand their effect on you.
Hair loss is a possible, typically temporary and dose-dependent side effect of Veprate 250mg Tablet ER. Consult your doctor if this side effect concerns you or continues.
Veprate 250mg Tablet ER can cause liver damage, particularly within the first six months of treatment. Symptoms of this may include nausea, vomiting, appetite loss, stomach pain, dark urine, facial swelling, and jaundice (yellowing of the skin or eyes). Liver function tests are crucial before starting and regularly during the initial six months, especially for at-risk individuals or those with a history of liver disease.
Refrain from alcohol while taking Veprate 250mg Extended-Release Tablets. Combining alcohol with this medication may increase drowsiness, dizziness, or lightheadedness.
Before starting Veprate 250mg Tablet ER treatment, your doctor may order blood tests. These may include a complete blood count (with platelet count), bleeding time, and coagulation tests to help prevent bleeding or bruising. Liver function tests are also recommended before and, for high-risk patients or those with liver disease, regularly during the first six months of treatment.
Severe abdominal pain, nausea, and vomiting may indicate pancreatitis. Seek immediate medical attention if you experience these symptoms. Your doctor may order a serum amylase test; a positive result necessitates immediate medication cessation.
Veprate 250mg ER tablet overdose can lead to headache, blurred vision (from constricted pupils), reduced reflexes, confusion, and fatigue. Further symptoms may include muscle weakness, seizures, unconsciousness, altered behavior, and respiratory problems like rapid breathing, shortness of breath, or chest pain. Seek immediate medical help if an overdose occurs.
Veprate 250mg Tablet ER
55
MRP 67
17% off